Want to see SHPH full AI Analyst Report?
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) Stock Statistics & Valuation Metrics
Total Valuation
Shuttle Pharmaceuticals Holdings, Inc. has a market cap or net worth of $24.54M. The enterprise value is $1.68T.
- Market Cap
- $24.54M
- Enterprise Value
- $1.68T
Share Statistics
Shuttle Pharmaceuticals Holdings, Inc. has 4,764,696 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 4,764,696
- Owned by Insiders
- 1.10%
- Owned by Institutions
- <0.01%
Financial Efficiency
Shuttle Pharmaceuticals Holdings, Inc.’s return on equity (ROE) is -5.20 and return on invested capital (ROIC) is -460.77%.
- Return on Equity (ROE)
- -5.20
- Return on Assets (ROA)
- -1.12
- Return on Invested Capital (ROIC)
- -460.77%
- Return on Capital Employed (ROCE)
- -4.75
- Revenue Per Employee
- 0
- Profits Per Employee
- -5.86M
- Employee Count
- 2
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Shuttle Pharmaceuticals Holdings, Inc. is -0.17. Shuttle Pharmaceuticals Holdings, Inc.’s PEG ratio is -0.01.
- PE Ratio
- -0.17
- PS Ratio
- 0.00
- PB Ratio
- 0.27
- Price to FCF
- -3.75
- Price to Operating Cash Flow
- -0.79
- PEG Ratio
- -0.01
Income Statement
In the last 12 months, Shuttle Pharmaceuticals Holdings, Inc. had revenue of 0 and earned -11.72M in profits. Earnings per share was -71.60.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -11.92M
- Pretax Income
- -11.72M
- Net Income
- -11.72M
- EBITDA
- -11.36M
- Earnings Per Share (EPS)
- -71.60
Cash Flow
In the last 12 months, operating cash flow was -6.58M and capital expenditures 36,004, giving a free cash flow of -6.55M billion.
- Operating Cash Flow
- -6.58M
- Free Cash Flow
- -6.55M
- Free Cash Flow per Share
- -6.45
Dividends & Yields
Shuttle Pharmaceuticals Holdings, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -26.69%
- Earnings Yield
- -196.25%
Stock Price Statistics
- Beta
- 1.49
- 52-Week Price Change
- -83.11%
- 50-Day Moving Average
- 4.15
- 200-Day Moving Average
- 6.82
- Relative Strength Index (RSI)
- 58.02
- Average Volume (3m)
- 72.67K
Important Dates
Shuttle Pharmaceuticals Holdings, Inc. upcoming earnings date is ―, After Close (Confirmed).
- Last Earnings Date
- Sep 04, 2024
- Next Earnings Date
- ―
- Ex-Dividend Date
- ―
Financial Position
Shuttle Pharmaceuticals Holdings, Inc. as a current ratio of 0.06, with Debt / Equity ratio of 10.30%
- Current Ratio
- 0.06
- Quick Ratio
- 0.06
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.01
- Interest Coverage Ratio
- -168.25
Taxes
In the past 12 months, Shuttle Pharmaceuticals Holdings, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Shuttle Pharmaceuticals Holdings, Inc. EV to EBITDA ratio is -2.61, with an EV/FCF ratio of -3.76.
- EV to Sales
- 0.00
- EV to EBITDA
- -2.61
- EV to Free Cash Flow
- -3.76
- EV to Operating Cash Flow
- -3.74
Balance Sheet
Shuttle Pharmaceuticals Holdings, Inc. has $90.24K in cash and marketable securities with $195.16K in debt, giving a net cash position of -$104.92K billion.
- Cash & Marketable Securities
- $90.24K
- Total Debt
- $195.16K
- Net Cash
- -$104.92K
- Net Cash Per Share
- -$0.02
- Tangible Book Value Per Share
- $10.38
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Shuttle Pharmaceuticals Holdings, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 94.90%
Scores
- Smart Score
- ―
- AI Score
- 32